Spontaneous eye blinking, a measure of dopaminergic function, in children with acquired immunodeficiency syndrome

Archives of Pediatrics and Adolescent Medicine

Volumn 151, Issue 10, 1997, Pages 1025-1032

  Vreugdenhil, Hestien ^a,c   Brouwers, Pim ^a   Walters, Pamela ^b   Bakker, Dirk ^c   Moss, Howard ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Medical Illness Counseling Center   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN ATROPHY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOPAMINERGIC SYSTEM; EMOTION; EYELID REFLEX; FAHR DISEASE; HUMAN; HYPERACTIVITY; MENTAL PERFORMANCE; PRIORITY JOURNAL; SCORING SYSTEM; WHITE MATTER;

EID: 0030723751     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1997.02170470059011     Document Type: Article

References (64)

1. Aylward EH, Butz AM, Hutton N, Joyner ML, Vogelhut JW. Cognitive and motor development in infants at risk for human immunodeficiency virus. AJDC. 1992;146:218-222.
2. Belman AL, Brouwers P, Moss H. HIV-1 and the central nervous system. In: Kaufman DM, Solomon GE, Pfeffer CR, eds. Child and Adolescent Neurology for Psychiatrists. Baltimore, Md: Williams & Wilkins; 1992:238-253.
3. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics. 1986;78:678-687.
4. Brouwers P, DeCarli C, Civitello LA, Moss H, Wolters P, Pizzo P. Correlation between computed tomographic brain scan abnormalities and neuropsychological function in children with symptomatic human immunodeficiency virus disease. Arch Neurol. 1995;52:39-44.
5. Epstein LG, Gendelman HE, Human Immunodeficiency virus type 1 infection of the nervous system: pathogenic mechanisms. Ann Neurol. 1993;33:429-436.
6. Lipton SA. HIV-related neuronal injury: potential therapeutic Intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol. 1994;8:181-196.
7. Chamberlain MC, Nichols SL, Chase CH. Pediatric AIDS: comparative cranial MRI and CT scans. Pediatr Neurol. 1991;7:357-362.
8. DeCarli C, Civitello LA, Brouwers P, Pizzo PA. The prevalence of computed axial tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immunodeficiency virus. Ann Neurol. 1993;34:198-205.
9. Kauffman WM, Sivit CJ, Fitz CR, Rakusan TA, Herzog K, Chandra RS. CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation. Am J Neuroradiol. 1992;13:949-957.
10. Kure K, Llena JF, Lyman WD, et al. Human Immunodeficiency virus-1 Infection of the nervous system. Hum Pathol. 1991;22:700-710.
11. Price DB, Inglese CM, Jacobs J, et al, Pediatric AIDS: neuroradiologic and neurodevelopmental findings. Pediatr Radiol. 1988;8:445-448.
12. Wiley CA, Belman AL, Dickson DW, Rubinstein A, Nelson JA. Human immunodeficiency virus within the brains of children with AIDS. Clin Neuropathol. 1990;9:1-6.
13. Wolters PL, Brouwers P, Moss HA, Pizzo PA. Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Pediatrics. 1995;95:112-119.
14. Moss HA, Wolters PL, Brouwers P, Hendricks ML, Pizzo PA. Impairment of expressive behavior In pediatric HIV-positive patients with evidence of CNS disease. J Pediatr Psychol. 1996;21:379-400.
15. Brouwers P, Mohr E, Hildebrand K, et al. A novel approach to the determination and characterization of HIV dementia. Can J Neurol Sci. 1996;23:104-109.
16. Martin A, HIV, cognition, and the basal ganglia. In: Grant I, Martin A, eds. Neuropsychology of HIV Infection. New York, NY: Oxford University Press; 1994:234-259.
17. Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B. Cerebrospinal fluid dopamine in HIV-1 Infection. AIDS. 1994;8:67-71.
18. Larsson M, Hagberg L, Forsman A, Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J Neurosci Res. 1991;28:406-409.
19. Mintz M, Tardieu M, Hoyt L, McSherry G, Mendelson J, Oleske J. Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes. Neurology. 1996;47:1583-1585.
20. Karson CN. Spontaneous eye-blink rates and dopaminergic systems. Brain. 1983;106:643-653.
21. Blin O, Masson G, Azulay JP, Fondaray J, Serratice G. Apomorphine-induced blinking and yawning in healthy volunteers. Br J Clin Pharmacol. 1990;30:769-773.
22. Karson CN, Staub RA, Kleinman JE, Wyatt RJ. Drug effect on blink rates in rhesus monkeys: preliminary studies. Biol Psychiatry. 1981;16:249-254.
23. 2 dopamine receptors independently regulate spontaneous blink rate in vervet monkey. J Pharmacol Exp Ther. 1991;259:595-600.
24. Hall A. The origin and purposes of blinking. Br J Ophthalmol. 1945;89:507-516.
25. Karson CN, Burns S, LeWitt PA, Foster NL, Newman RP. Blink rates and disorders of movements. Neurology. 1984;34:677-678.
26. Ponder E, Kennedy WP. On the act of blinking. Quart J Exp Physiol. 1927;18:89-119.
27. Kleinman JE, Karson CM, Weinberger DR, Freed WJ, Berman KF, Wyatt RJ, Eye-blinking and cerebral ventricle size in chronic schizophrenic patients. Am J Psychiatry. 1984;141:1430-1432.
28. Karson CN, Berman KF, Donnelly EF, Mendelson WB, Kleinman JE, Wyatt RJ. Speaking, thinking, and blinking. Psychiatr Res. 1981;5:243-246.
29. Telford CW, Thompson N. Some factors influencing voluntary and reflex eyelid responses. J Exp Psychol. 1933;16:524-539.
30. Zametkin AJ, Stevens JR, Pittman R. Ontogeny of spontaneous blinking and of distribution of the reflex blink. Ann Neurol. 1979;5:453-457.
31. Caplan R, Guthrie D. Blink rate in childhood schizophrenia spectrum disorder. Biol Psychiatry. 1994;35:228-234.
32. Brouwers P, Moss H, Wolters P, et al. Effect of continuous infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human Immunodeficiency virus infection. J Pediatr. 1990;117:980-985.
33. Butler KM, Husson RN, Balls FM, et al. Dideoxylnosine (ddl) in symptomatic HIV-infected children: a phase I-II study. N Engl J Med. 1991;324:137-144.
34. Wechsler D. Manual for the Wechsler Intelligence Scale for Children. New York, NY: Psychological Corp; 1974.
35. McCarthy D. Scales of Children's Abilities. New York, NY: Psychological Corp; 1972.
36. Bayley N. Manual for the Bayley Scales of Infant Development. San Antonio, Tex: Psychological Corp; 1969.
37. Brouwers P, Belman A, Epstein L. Central nervous system involvement: manifestations and evaluation. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. Baltimore, Md: Williams & Wilkins; 1991:318-335.
38. Moss HA, Brouwers P, Wolters PL, Wiener L, Hersh SP, Pizzo PA. The development of a Q-sort behavior rating procedure for pediatric HIV patients. J Pediatr Psychol. 1994;19:27-46.
39. European Collaborative Study. Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus-infected women. Pediatr Infect Dis J. 1992;11:1018-1026.
40. Brouwers P, Tudor-Williams G, DeCarll C, et al. Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease. AIDS. 1995;9:713-720.
41. + lymphocyte counts in healthy children born to human Immunodeficiency virus 1-infected parents. Pediatr Infect Dis J. 1994;13:70-72.
42. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology. 1989;39:119-122.
43. Belman AL. Acquired immunodeficiency syndrome and the child's central nervous system. Pediatr Clin North Am. 1992;39:691-714.
44. Bartko JJ, Carpenter WT. On the methods and theory of reliability. J Nerv Ment Dis. 1976;163:307-317.
45. Mackintosh JH, Kumar R, Kitamura T. Blink rate in psychiatric illness. Br J Psychiatry. 1983;143:55-57.
46. Depue RA, Iacono WG, Muir R, Arbisi P. Effect of phototherapy on spontaneous eye blink rate in subjects with seasonal affective disorder. Am J Psychiatry. 1988;145:1457-1459.
47. Brouwers P, van der Vlugt H, Moss H, Wolters P, Pizzo P. White matter changes on CT brain scan are associated with neurobehavioral dysfunction in children with symptomatic HIV disease. Child Neuropsychol. 1995;1:93-105.
48. Levy F. The dopamine theory of attention deficit hyperactivlty disorder (ADHD). Austr N Z J Psychiatry. 1991;25:277-283.
49. McCracken JT. A two-part model of stimulant action on attention-defict hyperactivity disorder in children. J Neuropsychiatry Clin Neurosci. 1991;3:201-209.
50. Caplan R, Guthrie D, Komo S. Blink rate in children with attention-deficit hyperactivity disorder. Biol Psychiatry. 1996;39:1032-1038.
51. Conners CK. Conners' Rating Scales, Manual. North Tonawanda, NY: Multi-Health Systems Inc; 1990.
52. Karson CN. Blinking. Bull Soc Belge Ophtalmol. 1989;237:443-457.
53. Karson CN, Dykman RA, Paige SR, Blink rates in schizophrenia. Schizophr Bull. 1990;16:345-354.
54. Freed WJ, Karson CN, Kleinman JE, Wyatt RJ, Increased spontaneous eye-blinks in cerebellectomized rats. Biol Psychiatry. 1981;16:789-792.
55. Volkmann FC, Riggs LA, Moore RK. Eyeblinks and visual suppression. Science. 1980;207:900-902.
56. Pycock CJ, Kerwin RW, Carter CJ, Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980;286:74-77.
57. Meltzer HY. Biochemical studies in schizophrenia. In: Bellak L, ed. Disorders of the Schizophrenic Syndrome. New York, NY: Basic Books; 1979:45-135.
58. Weinberger DR, Biggelow LB, Kleinman JE. Cerebral ventricular enlargement in chronic schizophrenia: association with poor response to treatment. Arch Gen Psychiatry, 1980;37:619-623.
59. Depas G, Chiron C, Tardieu M, et al. Functional brain imaging in HIV-1 infected children born to seropositive mothers. J Nucl Med. 1995;36:2169-2174.
60. Rottenberg DA, Moeller JR, Strocher SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol. 1987;22:700-706.
61. Lycke E, Roos BE. The monoamine metabolism in viral encephalitides of the mouse. Brain Res. 1972;44:603-613.
62. Pittaluga A, Pattarini R, Severi P, Raiteri M. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp 120. AIDS. 1996;10:463-468.
63. Sei S, Kleiner DE, Kopp JB, et al. Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction. J Infect Dis. 1994;170:325-333.
64. Sei S, Saito K, Stewart SK, et al. Increased HIV-1 DNA content and quinolinic acid concentration in brain tissues obtained from AIDS patients with HIV encephalopathy. J infect Dis. 1995;172:638-647.